Antiaging Quantum Living INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OID
Antiaging Quantum Living Inc. reported increased revenue for the nine months ended December 31, 2025, but also a higher net loss for the quarter, alongside a significant debt-to-equity conversion.
OID
Antiaging Quantum Living Inc. reported significantly reduced net losses and strong revenue growth for the six months ended September 30, 2025, driven by its technical support services, despite ongoing going concern issues and reliance on related party funding.
OID
Antiaging Quantum Living Inc. reported a reduced net loss of $133,372 for Q2 2025, driven by increased revenue and lower operating expenses, but continues to face substantial doubt about its ability to continue as a going concern.
OID
Antiaging Quantum Living Inc. reports a significant increase in revenue driven by online platform technical support, but also a widened net loss due to increased operating expenses for the quarter ended December 31, 2024.
OID
Antiaging Quantum Living Inc. saw a significant increase in revenue but also a substantial rise in net losses for the quarter ended September 30, 2024, compared to the same period last year.
OID
Antiaging Quantum Living Inc. saw a significant increase in revenue but also a substantial rise in net losses for the quarter ended June 30, 2024, compared to the same period last year.
OID
Antiaging Quantum Living Inc. reported increased net losses for the third quarter of 2024, driven by higher operating expenses related to business expansion, despite a slight increase in revenue.